Candel Therapeutics
Price & Volume
Stats
See moreOpen | $4.81 |
Previous Close | $4.83 |
Day Range | $4.79-$4.86 |
52W Range | $4.33-$7.25 |
Market Cap | $353.7M |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $31,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$23M |
Diluted EPS | -$0.72 |
News
See moreYahoo Finance • 28 days ago
Candel Therapeutics Reports Extended Survival Tail Observed in Trial of Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors
Yahoo Finance • last month
Candel Therapeutics GAAP EPS of -$0.54
Yahoo Finance • last month
Candel Therapeutics strengthens balance sheet as lead cancer therapy advances
About
CEO | Dr. Paul-Peter Tak FOCIS, M.D., Ph.D. |
CFO | Mr. Charles Schoch |
Address | 117 Kendrick Street, Needham, MA, United States, 02494 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 55 |
